Curative Biotechnology Inc (NYSE: CUBT) — Healthcare · Share Price, Chart & Market Data
About: Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.99 (-1.03%)
CUBTCurative Biotechnology Inc
Loading watchlist status…
Trade CUBT now
Curative Biotechnology Inc share price
CUBT price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:13 am GMT+0
CUBT price performance
-13.184%
5D
-44.709%
1M
20,097.959%
YTD
9,699.01%
1Y
CUBT price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:13 am GMT+0
CUBT details
CUBT Market Signals